Skip to content

Left atrial appendage clOsureVia the guidance of intracardiac Echocardiography (LOVE): multicenter cohort study

Left atrial appendage closure under the guidance of intracardiac echocardiography

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041103
Enrollment
Unknown
Registered
2020-12-17
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

ICE group:ICE-guided LAAC procedures
TEE group:TEE-guided LAAC procedures

Sponsors

Ningbo First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who can't tolerate or are unwilling to accept TEE examination, or who are not suitable for TEE examination due to esophageal lesions (infection, ulcer, space occupying, etc.); 2; 2. Patients with atrial septal puncture difficulties predicted by the operator (such as dextrocardia, spinal deformity, cardiac transposition, less experience of atrial septal puncture under X-ray, etc.); 3. Patients with renal insufficiency or allergic to contrast medium; 4. Patients who are not suitable for X-ray exposure due to special constitution or physiological state, or who are allergic to X-ray irradiation; 5. Patients whose left atrial appendage occlusion effect cannot be accurately judged under X-ray.

Exclusion criteria

Exclusion criteria: 1. Patients with congenital heart disease, valvular heart disease, acute myocardial infarction, severe myocarditis, pulmonary heart disease, severe infection, autoimmune disease, hematological disease and malignant tumor; 2. Patients with NYHA grade IV or left ventricular ejection fraction <= 35% by echocardiography, who can not tolerate LAAC operation; 3. Patients with thrombus in left atrium or left atrial appendage (confirmed by ice or tee or CCTA before operation); 4. Those patients who underwent one-stop surgery for atrial fibrillation; 5. Patients with serious nervous system diseases and mental diseases (including drug abuse, chronic alcoholism, etc.); 6. Patients who cannot tolerate short-term oral anticoagulation or antiplatelet aggregation therapy after operation; 7. Patients with a history of cardiac surgery in the past 6 months; 8. Patients with life expectancy less than 12 months; 9. Subjects who have participated in other clinical studies within 3 months before the date of informed consent or are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
LAAC acute success rate;acute complete closure rate;Incidence of peri-device leaks during follow-up;Percentage of discontinuation of oral anticoagulants;

Secondary

MeasureTime frame
procedure-related parameters;peri-procedural complication rate;incidence of adverse events during follow-up;

Countries

China

Contacts

Public ContactHuimin Chu

Cardiac Arrhythmia Center, Ningbo First Hospital

epnbheart@163.com+86 574-87085226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026